Answers are grounded in this paper and cite their sources.
In Brief Overlooked for decades, the humoral alloimmune response is increasingly recognized as a leading cause of graft loss after transplantation. However, improvement in the diagnosis of antibody-mediated rejection has not yet translated into better outcomes for transplanted patients. After an update on B cell physiology and antibody generation, the 2015 Beaune Seminar in Transplant Research challenged the conventional view of antibody-mediated rejection pathophysiology and discussed the latest promising therapeutic approaches. A summary of the 2015 Beaune Seminars in Transplant Research discussing issues related to B cell physiology and antibody generation, current state in diagnosing pathogenic DSA and antibody-mediated rejection, and new treatment strategies.
No takes yet. Share an insight, caveat, or question.
Koenig et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: